An Argonne
technology originally designed to cool urban buildings may have
a new life saving lives of cardiac arrest victims. Coronary
heart disease, which often leads to cardiac arrests, is the No.
1 cause of death in America. It claims more than 250,000 lives
every year.
Researchers
in Argonne’s Energy Technology
Division and the University
of Chicago’s Emergency Resuscitation
Center are employing the cooling to decrease the devastating
effects of
sudden
cardiac arrests.
Using a five-year,
$4-million grant from the National
Institutes of Health, researchers
are expanding work
on the medical application
of ice slurry—a mixture of ice and salt water that
may be injected into the lungs for rapid blood cooling to sustain
the heart and brain cells after cardiac arrests.
Ice slurry
is an equal mix of ultra-small—equivalent to
the diameter of a human hair—ice particles and salt-water
liquid carrier.
“In the
United States alone,” said Roger Poeppel, Energy Technology
Division director, “sudden cardiac arrests strike
about 1,000 people a day, and the survival rate is at best
2 percent to 4 percent.
If we can improve survival rate by just 1 percent, we will
save the lives of 10 people every day.”
People who
suffer cardiac arrests outside of the hospital have a
lower recovery rate. Brain cells start dying rapidly
10 to
12 minutes after an arrest because of lack of blood flow
to the brain.
In 1999, Ken
Kasza, a senior mechanical engineer who leads the research at
Argonne, and Poeppel worked
with
collaborators
Lance
Becker and Terry Vanden Hoek from the University
of Chicago Hospitals to develop the Emergency Resuscitation
Center to investigate
brain cooling using ice slurry to improve recovery
rate.
When cells
cool, their metabolism and their chemical processes slow dramatically.
Because external cooling
works too slowly,
the team is studying injecting ice slurry into the
body to induce rapid
internal cooling. Ice slurry’s high cooling
capacity would cool critical organs rapidly.
In the
procedure, slurry would be inserted into the
lungs, cooling the surrounding blood. Medics must
perform chest
compressions to circulate the cooled blood, allowing
it to reach the brain
and
preserve brain cells. The ice slurry slowly melts
in the body and is removed with a suction device
on the
end of
the endotracheal
tube.
Data collected
by the Argonne-university team has shown that the ice slurry
can cool the brain by
10.8 degrees
Fahrenheit
within
10 minutes. The brain remains chilled for an
hour, which in real life would give doctors more time
to revive normal
heart,
blood
flow and brain activity. This, hopefully, will
reduce or stop brain damage.
Kasza and Becker
said if the ice slurry procedure is eventually approved, it
will still be secondary
to
defibrillation.
Other challenges
still remain for the slurry and cardiac arrest treatment. For
example,
researchers still need
to find the
optimal cooling level of ice slurry, the
correct timing and protocols,
the appropriate toxicity levels, and to determine
how much of the brain survives after ice
slurry is used.
“We hope
to see the medical application of slurry used by first responders
as a common procedure in the next three to five years,” Kasza
said. “With this funding and support,
we’ll be able
to answer the questions to get us to that
point.”
Also see:
http://www.anl.gov/OPA/logos21-1/ice01.htm.
For more information,
please contact Evelyn Brown.
Next: Plentiful
stem cell source found in human blood
Back
to top
|